Global Beta-Nicotinamide Mononucleotide (NMN) Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
The global Beta-Nicotinamide Mononucleotide (NMN) market size is projected to grow from US$ 401 million in 2024 to US$ 763 million in 2030; it is expected to grow at a CAGR of 11.3% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Beta-Nicotinamide Mononucleotide (NMN) Industry Forecast” looks at past sales and reviews total world Beta-Nicotinamide Mononucleotide (NMN) sales in 2023, providing a comprehensive analysis by region and market sector of projected Beta-Nicotinamide Mononucleotide (NMN) sales for 2024 through 2030. With Beta-Nicotinamide Mononucleotide (NMN) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Beta-Nicotinamide Mononucleotide (NMN) industry.
This Insight Report provides a comprehensive analysis of the global Beta-Nicotinamide Mononucleotide (NMN) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Beta-Nicotinamide Mononucleotide (NMN) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Beta-Nicotinamide Mononucleotide (NMN) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Beta-Nicotinamide Mononucleotide (NMN) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Beta-Nicotinamide Mononucleotide (NMN).
Core manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Mirarailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production region, accounting for approximately 64% of the global market, followed by Japan and North America. In terms of product type, products with content ?98% are the largest market segment, with a share of more than 99%. In terms of product application, the largest application market is health care products, with a share of approximately 99%.
This report presents a comprehensive overview, market shares, and growth opportunities of Beta-Nicotinamide Mononucleotide (NMN) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Beta-Nicotinamide Mononucleotide (NMN) market?
What factors are driving Beta-Nicotinamide Mononucleotide (NMN) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Beta-Nicotinamide Mononucleotide (NMN) market opportunities vary by end market size?
How does Beta-Nicotinamide Mononucleotide (NMN) break out by Type, by Application?
Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.
The global Beta-Nicotinamide Mononucleotide (NMN) market size is projected to grow from US$ 401 million in 2024 to US$ 763 million in 2030; it is expected to grow at a CAGR of 11.3% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Beta-Nicotinamide Mononucleotide (NMN) Industry Forecast” looks at past sales and reviews total world Beta-Nicotinamide Mononucleotide (NMN) sales in 2023, providing a comprehensive analysis by region and market sector of projected Beta-Nicotinamide Mononucleotide (NMN) sales for 2024 through 2030. With Beta-Nicotinamide Mononucleotide (NMN) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Beta-Nicotinamide Mononucleotide (NMN) industry.
This Insight Report provides a comprehensive analysis of the global Beta-Nicotinamide Mononucleotide (NMN) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Beta-Nicotinamide Mononucleotide (NMN) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Beta-Nicotinamide Mononucleotide (NMN) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Beta-Nicotinamide Mononucleotide (NMN) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Beta-Nicotinamide Mononucleotide (NMN).
Core manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Mirarailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production region, accounting for approximately 64% of the global market, followed by Japan and North America. In terms of product type, products with content ?98% are the largest market segment, with a share of more than 99%. In terms of product application, the largest application market is health care products, with a share of approximately 99%.
This report presents a comprehensive overview, market shares, and growth opportunities of Beta-Nicotinamide Mononucleotide (NMN) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Content ?98%
- Content ?98%
- Health Care Products
- Cosmetics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GeneHarbor
- Herbalmax
- Genex Formulas
- Mirailab Bioscience
- Maac10 Formulas
- EffePharm
- Bontac
- CELFULL
- Kingdomway
What is the 10-year outlook for the global Beta-Nicotinamide Mononucleotide (NMN) market?
What factors are driving Beta-Nicotinamide Mononucleotide (NMN) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Beta-Nicotinamide Mononucleotide (NMN) market opportunities vary by end market size?
How does Beta-Nicotinamide Mononucleotide (NMN) break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Beta-Nicotinamide Mononucleotide (NMN) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Beta-Nicotinamide Mononucleotide (NMN) by Country/Region, 2019, 2023 & 2030
2.2 Beta-Nicotinamide Mononucleotide (NMN) Segment by Type
2.2.1 Content ?98%
2.2.2 Content ?98%
2.3 Beta-Nicotinamide Mononucleotide (NMN) Sales by Type
2.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
2.3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sale Price by Type (2019-2024)
2.4 Beta-Nicotinamide Mononucleotide (NMN) Segment by Application
2.4.1 Health Care Products
2.4.2 Cosmetics
2.4.3 Others
2.5 Beta-Nicotinamide Mononucleotide (NMN) Sales by Application
2.5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2019-2024)
2.5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Breakdown Data by Company
3.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Sales by Company (2019-2024)
3.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2019-2024)
3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Revenue by Company (2019-2024)
3.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Company (2019-2024)
3.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2019-2024)
3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sale Price by Company
3.4 Key Manufacturers Beta-Nicotinamide Mononucleotide (NMN) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Beta-Nicotinamide Mononucleotide (NMN) Product Location Distribution
3.4.2 Players Beta-Nicotinamide Mononucleotide (NMN) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) BY GEOGRAPHIC REGION
4.1 World Historic Beta-Nicotinamide Mononucleotide (NMN) Market Size by Geographic Region (2019-2024)
4.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country/Region (2019-2024)
4.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Beta-Nicotinamide Mononucleotide (NMN) Sales Growth
4.4 APAC Beta-Nicotinamide Mononucleotide (NMN) Sales Growth
4.5 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Growth
4.6 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Growth
5 AMERICAS
5.1 Americas Beta-Nicotinamide Mononucleotide (NMN) Sales by Country
5.1.1 Americas Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024)
5.1.2 Americas Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024)
5.2 Americas Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
5.3 Americas Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Beta-Nicotinamide Mononucleotide (NMN) Sales by Region
6.1.1 APAC Beta-Nicotinamide Mononucleotide (NMN) Sales by Region (2019-2024)
6.1.2 APAC Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region (2019-2024)
6.2 APAC Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
6.3 APAC Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Beta-Nicotinamide Mononucleotide (NMN) by Country
7.1.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024)
7.1.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024)
7.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
7.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) by Country
8.1.1 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024)
8.2 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
8.3 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Beta-Nicotinamide Mononucleotide (NMN)
10.3 Manufacturing Process Analysis of Beta-Nicotinamide Mononucleotide (NMN)
10.4 Industry Chain Structure of Beta-Nicotinamide Mononucleotide (NMN)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Beta-Nicotinamide Mononucleotide (NMN) Distributors
11.3 Beta-Nicotinamide Mononucleotide (NMN) Customer
12 WORLD FORECAST REVIEW FOR BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) BY GEOGRAPHIC REGION
12.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Region
12.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Forecast by Region (2025-2030)
12.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Beta-Nicotinamide Mononucleotide (NMN) Forecast by Type (2025-2030)
12.7 Global Beta-Nicotinamide Mononucleotide (NMN) Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 GeneHarbor
13.1.1 GeneHarbor Company Information
13.1.2 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GeneHarbor Main Business Overview
13.1.5 GeneHarbor Latest Developments
13.2 Herbalmax
13.2.1 Herbalmax Company Information
13.2.2 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Herbalmax Main Business Overview
13.2.5 Herbalmax Latest Developments
13.3 Genex Formulas
13.3.1 Genex Formulas Company Information
13.3.2 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Genex Formulas Main Business Overview
13.3.5 Genex Formulas Latest Developments
13.4 Mirailab Bioscience
13.4.1 Mirailab Bioscience Company Information
13.4.2 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.4.3 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Mirailab Bioscience Main Business Overview
13.4.5 Mirailab Bioscience Latest Developments
13.5 Maac10 Formulas
13.5.1 Maac10 Formulas Company Information
13.5.2 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Maac10 Formulas Main Business Overview
13.5.5 Maac10 Formulas Latest Developments
13.6 EffePharm
13.6.1 EffePharm Company Information
13.6.2 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 EffePharm Main Business Overview
13.6.5 EffePharm Latest Developments
13.7 Bontac
13.7.1 Bontac Company Information
13.7.2 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Bontac Main Business Overview
13.7.5 Bontac Latest Developments
13.8 CELFULL
13.8.1 CELFULL Company Information
13.8.2 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 CELFULL Main Business Overview
13.8.5 CELFULL Latest Developments
13.9 Kingdomway
13.9.1 Kingdomway Company Information
13.9.2 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Kingdomway Main Business Overview
13.9.5 Kingdomway Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Beta-Nicotinamide Mononucleotide (NMN) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Beta-Nicotinamide Mononucleotide (NMN) by Country/Region, 2019, 2023 & 2030
2.2 Beta-Nicotinamide Mononucleotide (NMN) Segment by Type
2.2.1 Content ?98%
2.2.2 Content ?98%
2.3 Beta-Nicotinamide Mononucleotide (NMN) Sales by Type
2.3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
2.3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sale Price by Type (2019-2024)
2.4 Beta-Nicotinamide Mononucleotide (NMN) Segment by Application
2.4.1 Health Care Products
2.4.2 Cosmetics
2.4.3 Others
2.5 Beta-Nicotinamide Mononucleotide (NMN) Sales by Application
2.5.1 Global Beta-Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2019-2024)
2.5.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Beta-Nicotinamide Mononucleotide (NMN) Breakdown Data by Company
3.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Sales by Company (2019-2024)
3.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2019-2024)
3.2 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Revenue by Company (2019-2024)
3.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Company (2019-2024)
3.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2019-2024)
3.3 Global Beta-Nicotinamide Mononucleotide (NMN) Sale Price by Company
3.4 Key Manufacturers Beta-Nicotinamide Mononucleotide (NMN) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Beta-Nicotinamide Mononucleotide (NMN) Product Location Distribution
3.4.2 Players Beta-Nicotinamide Mononucleotide (NMN) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) BY GEOGRAPHIC REGION
4.1 World Historic Beta-Nicotinamide Mononucleotide (NMN) Market Size by Geographic Region (2019-2024)
4.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Beta-Nicotinamide Mononucleotide (NMN) Market Size by Country/Region (2019-2024)
4.2.1 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Beta-Nicotinamide Mononucleotide (NMN) Sales Growth
4.4 APAC Beta-Nicotinamide Mononucleotide (NMN) Sales Growth
4.5 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Growth
4.6 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Growth
5 AMERICAS
5.1 Americas Beta-Nicotinamide Mononucleotide (NMN) Sales by Country
5.1.1 Americas Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024)
5.1.2 Americas Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024)
5.2 Americas Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
5.3 Americas Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Beta-Nicotinamide Mononucleotide (NMN) Sales by Region
6.1.1 APAC Beta-Nicotinamide Mononucleotide (NMN) Sales by Region (2019-2024)
6.1.2 APAC Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region (2019-2024)
6.2 APAC Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
6.3 APAC Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Beta-Nicotinamide Mononucleotide (NMN) by Country
7.1.1 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024)
7.1.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024)
7.2 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
7.3 Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) by Country
8.1.1 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024)
8.2 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024)
8.3 Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Beta-Nicotinamide Mononucleotide (NMN)
10.3 Manufacturing Process Analysis of Beta-Nicotinamide Mononucleotide (NMN)
10.4 Industry Chain Structure of Beta-Nicotinamide Mononucleotide (NMN)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Beta-Nicotinamide Mononucleotide (NMN) Distributors
11.3 Beta-Nicotinamide Mononucleotide (NMN) Customer
12 WORLD FORECAST REVIEW FOR BETA-NICOTINAMIDE MONONUCLEOTIDE (NMN) BY GEOGRAPHIC REGION
12.1 Global Beta-Nicotinamide Mononucleotide (NMN) Market Size Forecast by Region
12.1.1 Global Beta-Nicotinamide Mononucleotide (NMN) Forecast by Region (2025-2030)
12.1.2 Global Beta-Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Beta-Nicotinamide Mononucleotide (NMN) Forecast by Type (2025-2030)
12.7 Global Beta-Nicotinamide Mononucleotide (NMN) Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 GeneHarbor
13.1.1 GeneHarbor Company Information
13.1.2 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GeneHarbor Main Business Overview
13.1.5 GeneHarbor Latest Developments
13.2 Herbalmax
13.2.1 Herbalmax Company Information
13.2.2 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.2.3 Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Herbalmax Main Business Overview
13.2.5 Herbalmax Latest Developments
13.3 Genex Formulas
13.3.1 Genex Formulas Company Information
13.3.2 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Genex Formulas Main Business Overview
13.3.5 Genex Formulas Latest Developments
13.4 Mirailab Bioscience
13.4.1 Mirailab Bioscience Company Information
13.4.2 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.4.3 Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Mirailab Bioscience Main Business Overview
13.4.5 Mirailab Bioscience Latest Developments
13.5 Maac10 Formulas
13.5.1 Maac10 Formulas Company Information
13.5.2 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Maac10 Formulas Main Business Overview
13.5.5 Maac10 Formulas Latest Developments
13.6 EffePharm
13.6.1 EffePharm Company Information
13.6.2 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.6.3 EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 EffePharm Main Business Overview
13.6.5 EffePharm Latest Developments
13.7 Bontac
13.7.1 Bontac Company Information
13.7.2 Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.7.3 Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Bontac Main Business Overview
13.7.5 Bontac Latest Developments
13.8 CELFULL
13.8.1 CELFULL Company Information
13.8.2 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.8.3 CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 CELFULL Main Business Overview
13.8.5 CELFULL Latest Developments
13.9 Kingdomway
13.9.1 Kingdomway Company Information
13.9.2 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
13.9.3 Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Kingdomway Main Business Overview
13.9.5 Kingdomway Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Beta-Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Beta-Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Content ?98%
Table 4. Major Players of Content ?98%
Table 5. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 6. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Table 7. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2019-2024) & ($ million)
Table 8. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2019-2024)
Table 9. Global Beta-Nicotinamide Mononucleotide (NMN) Sale Price by Type (2019-2024) & (US$/Kg)
Table 10. Global Beta-Nicotinamide Mononucleotide (NMN) Sale by Application (2019-2024) & (Tons)
Table 11. Global Beta-Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2019-2024)
Table 12. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2024) & ($ million)
Table 13. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2019-2024)
Table 14. Global Beta-Nicotinamide Mononucleotide (NMN) Sale Price by Application (2019-2024) & (US$/Kg)
Table 15. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Company (2019-2024) & (Tons)
Table 16. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2019-2024)
Table 17. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2019-2024)
Table 19. Global Beta-Nicotinamide Mononucleotide (NMN) Sale Price by Company (2019-2024) & (US$/Kg)
Table 20. Key Manufacturers Beta-Nicotinamide Mononucleotide (NMN) Producing Area Distribution and Sales Area
Table 21. Players Beta-Nicotinamide Mononucleotide (NMN) Products Offered
Table 22. Beta-Nicotinamide Mononucleotide (NMN) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2019-2024) & (Tons)
Table 26. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share Geographic Region (2019-2024)
Table 27. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Country/Region (2019-2024) & (Tons)
Table 30. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2019-2024)
Table 31. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Tons)
Table 34. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2019-2024)
Table 35. Americas Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 37. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 38. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales by Region (2019-2024) & (Tons)
Table 39. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2019-2024)
Table 40. APAC Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 42. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 43. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Tons)
Table 44. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 46. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 47. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Tons)
Table 48. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 50. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Beta-Nicotinamide Mononucleotide (NMN)
Table 52. Key Market Challenges & Risks of Beta-Nicotinamide Mononucleotide (NMN)
Table 53. Key Industry Trends of Beta-Nicotinamide Mononucleotide (NMN)
Table 54. Beta-Nicotinamide Mononucleotide (NMN) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Beta-Nicotinamide Mononucleotide (NMN) Distributors List
Table 57. Beta-Nicotinamide Mononucleotide (NMN) Customer List
Table 58. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2025-2030) & (Tons)
Table 59. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2025-2030) & (Tons)
Table 61. Americas Beta-Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2025-2030) & (Tons)
Table 63. APAC Beta-Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2025-2030) & (Tons)
Table 65. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2025-2030) & (Tons)
Table 67. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2025-2030) & (Tons)
Table 69. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2025-2030) & (Tons)
Table 71. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. GeneHarbor Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 73. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 74. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 75. GeneHarbor Main Business
Table 76. GeneHarbor Latest Developments
Table 77. Herbalmax Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 78. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 79. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 80. Herbalmax Main Business
Table 81. Herbalmax Latest Developments
Table 82. Genex Formulas Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 83. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 84. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 85. Genex Formulas Main Business
Table 86. Genex Formulas Latest Developments
Table 87. Mirailab Bioscience Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 88. Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 89. Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 90. Mirailab Bioscience Main Business
Table 91. Mirailab Bioscience Latest Developments
Table 92. Maac10 Formulas Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 93. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 94. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 95. Maac10 Formulas Main Business
Table 96. Maac10 Formulas Latest Developments
Table 97. EffePharm Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 98. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 99. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 100. EffePharm Main Business
Table 101. EffePharm Latest Developments
Table 102. Bontac Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 103. Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 104. Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 105. Bontac Main Business
Table 106. Bontac Latest Developments
Table 107. CELFULL Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 108. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 109. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 110. CELFULL Main Business
Table 111. CELFULL Latest Developments
Table 112. Kingdomway Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 113. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 114. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 115. Kingdomway Main Business
Table 116. Kingdomway Latest Developments
Table 1. Beta-Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Beta-Nicotinamide Mononucleotide (NMN) Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Content ?98%
Table 4. Major Players of Content ?98%
Table 5. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 6. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Table 7. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Type (2019-2024) & ($ million)
Table 8. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2019-2024)
Table 9. Global Beta-Nicotinamide Mononucleotide (NMN) Sale Price by Type (2019-2024) & (US$/Kg)
Table 10. Global Beta-Nicotinamide Mononucleotide (NMN) Sale by Application (2019-2024) & (Tons)
Table 11. Global Beta-Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2019-2024)
Table 12. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Application (2019-2024) & ($ million)
Table 13. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application (2019-2024)
Table 14. Global Beta-Nicotinamide Mononucleotide (NMN) Sale Price by Application (2019-2024) & (US$/Kg)
Table 15. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Company (2019-2024) & (Tons)
Table 16. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company (2019-2024)
Table 17. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company (2019-2024)
Table 19. Global Beta-Nicotinamide Mononucleotide (NMN) Sale Price by Company (2019-2024) & (US$/Kg)
Table 20. Key Manufacturers Beta-Nicotinamide Mononucleotide (NMN) Producing Area Distribution and Sales Area
Table 21. Players Beta-Nicotinamide Mononucleotide (NMN) Products Offered
Table 22. Beta-Nicotinamide Mononucleotide (NMN) Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2019-2024) & (Tons)
Table 26. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share Geographic Region (2019-2024)
Table 27. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Beta-Nicotinamide Mononucleotide (NMN) Sales by Country/Region (2019-2024) & (Tons)
Table 30. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2019-2024)
Table 31. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Tons)
Table 34. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2019-2024)
Table 35. Americas Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 37. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 38. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales by Region (2019-2024) & (Tons)
Table 39. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region (2019-2024)
Table 40. APAC Beta-Nicotinamide Mononucleotide (NMN) Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 42. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 43. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Tons)
Table 44. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 46. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 47. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Country (2019-2024) & (Tons)
Table 48. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Type (2019-2024) & (Tons)
Table 50. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales by Application (2019-2024) & (Tons)
Table 51. Key Market Drivers & Growth Opportunities of Beta-Nicotinamide Mononucleotide (NMN)
Table 52. Key Market Challenges & Risks of Beta-Nicotinamide Mononucleotide (NMN)
Table 53. Key Industry Trends of Beta-Nicotinamide Mononucleotide (NMN)
Table 54. Beta-Nicotinamide Mononucleotide (NMN) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Beta-Nicotinamide Mononucleotide (NMN) Distributors List
Table 57. Beta-Nicotinamide Mononucleotide (NMN) Customer List
Table 58. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2025-2030) & (Tons)
Table 59. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2025-2030) & (Tons)
Table 61. Americas Beta-Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales Forecast by Region (2025-2030) & (Tons)
Table 63. APAC Beta-Nicotinamide Mononucleotide (NMN) Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2025-2030) & (Tons)
Table 65. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Forecast by Country (2025-2030) & (Tons)
Table 67. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Forecast by Type (2025-2030) & (Tons)
Table 69. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Forecast by Application (2025-2030) & (Tons)
Table 71. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. GeneHarbor Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 73. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 74. GeneHarbor Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 75. GeneHarbor Main Business
Table 76. GeneHarbor Latest Developments
Table 77. Herbalmax Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 78. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 79. Herbalmax Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 80. Herbalmax Main Business
Table 81. Herbalmax Latest Developments
Table 82. Genex Formulas Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 83. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 84. Genex Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 85. Genex Formulas Main Business
Table 86. Genex Formulas Latest Developments
Table 87. Mirailab Bioscience Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 88. Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 89. Mirailab Bioscience Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 90. Mirailab Bioscience Main Business
Table 91. Mirailab Bioscience Latest Developments
Table 92. Maac10 Formulas Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 93. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 94. Maac10 Formulas Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 95. Maac10 Formulas Main Business
Table 96. Maac10 Formulas Latest Developments
Table 97. EffePharm Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 98. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 99. EffePharm Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 100. EffePharm Main Business
Table 101. EffePharm Latest Developments
Table 102. Bontac Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 103. Bontac Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 104. Bontac Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 105. Bontac Main Business
Table 106. Bontac Latest Developments
Table 107. CELFULL Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 108. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 109. CELFULL Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 110. CELFULL Main Business
Table 111. CELFULL Latest Developments
Table 112. Kingdomway Basic Information, Beta-Nicotinamide Mononucleotide (NMN) Manufacturing Base, Sales Area and Its Competitors
Table 113. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Product Portfolios and Specifications
Table 114. Kingdomway Beta-Nicotinamide Mononucleotide (NMN) Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 115. Kingdomway Main Business
Table 116. Kingdomway Latest Developments
LIST OF FIGURES
Figure 1. Picture of Beta-Nicotinamide Mononucleotide (NMN)
Figure 2. Beta-Nicotinamide Mononucleotide (NMN) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Beta-Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2023)
Figure 10. Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Content ?98%
Figure 12. Product Picture of Content ?98%
Figure 13. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type in 2023
Figure 14. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2019-2024)
Figure 15. Beta-Nicotinamide Mononucleotide (NMN) Consumed in Health Care Products
Figure 16. Global Beta-Nicotinamide Mononucleotide (NMN) Market: Health Care Products (2019-2024) & (Tons)
Figure 17. Beta-Nicotinamide Mononucleotide (NMN) Consumed in Cosmetics
Figure 18. Global Beta-Nicotinamide Mononucleotide (NMN) Market: Cosmetics (2019-2024) & (Tons)
Figure 19. Beta-Nicotinamide Mononucleotide (NMN) Consumed in Others
Figure 20. Global Beta-Nicotinamide Mononucleotide (NMN) Market: Others (2019-2024) & (Tons)
Figure 21. Global Beta-Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2023)
Figure 22. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2023
Figure 23. Beta-Nicotinamide Mononucleotide (NMN) Sales by Company in 2023 (Tons)
Figure 24. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company in 2023
Figure 25. Beta-Nicotinamide Mononucleotide (NMN) Revenue by Company in 2023 ($ millions)
Figure 26. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company in 2023
Figure 27. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 30. Americas Beta-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 31. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 32. APAC Beta-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 33. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 34. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 36. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 37. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2023
Figure 38. Americas Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2019-2024)
Figure 39. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 40. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 41. United States Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region in 2023
Figure 46. APAC Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2019-2024)
Figure 47. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 48. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 49. China Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 53. India Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2023
Figure 57. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2019-2024)
Figure 58. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 59. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 60. Germany Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 61. France Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 68. Egypt Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Beta-Nicotinamide Mononucleotide (NMN) in 2023
Figure 74. Manufacturing Process Analysis of Beta-Nicotinamide Mononucleotide (NMN)
Figure 75. Industry Chain Structure of Beta-Nicotinamide Mononucleotide (NMN)
Figure 76. Channels of Distribution
Figure 77. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Forecast by Region (2025-2030)
Figure 78. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Beta-Nicotinamide Mononucleotide (NMN)
Figure 2. Beta-Nicotinamide Mononucleotide (NMN) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Growth Rate 2019-2030 (Tons)
Figure 7. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Beta-Nicotinamide Mononucleotide (NMN) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2023)
Figure 10. Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Content ?98%
Figure 12. Product Picture of Content ?98%
Figure 13. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type in 2023
Figure 14. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Type (2019-2024)
Figure 15. Beta-Nicotinamide Mononucleotide (NMN) Consumed in Health Care Products
Figure 16. Global Beta-Nicotinamide Mononucleotide (NMN) Market: Health Care Products (2019-2024) & (Tons)
Figure 17. Beta-Nicotinamide Mononucleotide (NMN) Consumed in Cosmetics
Figure 18. Global Beta-Nicotinamide Mononucleotide (NMN) Market: Cosmetics (2019-2024) & (Tons)
Figure 19. Beta-Nicotinamide Mononucleotide (NMN) Consumed in Others
Figure 20. Global Beta-Nicotinamide Mononucleotide (NMN) Market: Others (2019-2024) & (Tons)
Figure 21. Global Beta-Nicotinamide Mononucleotide (NMN) Sale Market Share by Application (2023)
Figure 22. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Application in 2023
Figure 23. Beta-Nicotinamide Mononucleotide (NMN) Sales by Company in 2023 (Tons)
Figure 24. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Company in 2023
Figure 25. Beta-Nicotinamide Mononucleotide (NMN) Revenue by Company in 2023 ($ millions)
Figure 26. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Company in 2023
Figure 27. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 30. Americas Beta-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 31. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 32. APAC Beta-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 33. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 34. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales 2019-2024 (Tons)
Figure 36. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue 2019-2024 ($ millions)
Figure 37. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2023
Figure 38. Americas Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2019-2024)
Figure 39. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 40. Americas Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 41. United States Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Region in 2023
Figure 46. APAC Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Region (2019-2024)
Figure 47. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 48. APAC Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 49. China Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 53. India Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country in 2023
Figure 57. Europe Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share by Country (2019-2024)
Figure 58. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 59. Europe Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 60. Germany Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 61. France Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share by Application (2019-2024)
Figure 68. Egypt Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Beta-Nicotinamide Mononucleotide (NMN) Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Beta-Nicotinamide Mononucleotide (NMN) in 2023
Figure 74. Manufacturing Process Analysis of Beta-Nicotinamide Mononucleotide (NMN)
Figure 75. Industry Chain Structure of Beta-Nicotinamide Mononucleotide (NMN)
Figure 76. Channels of Distribution
Figure 77. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Forecast by Region (2025-2030)
Figure 78. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Beta-Nicotinamide Mononucleotide (NMN) Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Beta-Nicotinamide Mononucleotide (NMN) Revenue Market Share Forecast by Application (2025-2030)
